{
    "clinical_study": {
        "@rank": "48598", 
        "brief_summary": {
            "textblock": "The purpose of this study is to learn about gait (walking) characteristics in MPS IVA and\n      possible changes in gait with enzyme replacement therapy."
        }, 
        "brief_title": "Gait Analysis in MPS IVA", 
        "completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "MPS IVA", 
            "Morquio Syndrome"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Mucopolysaccharidosis IV", 
                "Osteochondrodysplasias"
            ]
        }, 
        "detailed_description": {
            "textblock": "The purpose of this 3-year study is to conduct a longitudinal investigation using motion\n      analysis of gait to objectively and quantitatively assess gait characteristics of MPS IVA\n      patients.  Data documenting gait characteristics and abnormalities will be gathered in\n      patients initiating enzyme replacement therapy.\n\n      Inclusion criteria Individuals with MPS IVA diagnosed by enzyme or molecular studies\n      Exclusion Criteria Individual with MPS IVA previously enrolled in BMN-110 Individual is\n      non-ambulatory The individual is unable to complete longitudinal study visits at least\n      yearly"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        -Diagnosis of MPS IVA\n\n        Exclusion Criteria:\n\n        Non-ambulatory\n\n          -  Previous enrolled in clinical trial BMN-110"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "1 Year", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with a diagnosis of MPS IVA"
            }
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01920828", 
            "org_study_id": "OregonHSU-8833"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 9, 2013", 
        "location": {
            "contact": {
                "email": "hata@ohsu.edu", 
                "last_name": "Abigail Hata, MS CGC", 
                "phone": "503-418-1061"
            }, 
            "facility": {
                "address": {
                    "city": "Portland", 
                    "country": "United States", 
                    "state": "Oregon", 
                    "zip": "97239"
                }, 
                "name": "Oregon Health and Science University"
            }, 
            "investigator": {
                "last_name": "Abigail Hata, MS CGC", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Gait Analysis in Patients With MPS IVA Treated With Enzyme Replacement Therapy", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Data and Safety Monitoring Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Data acquired on patients will be compared with age-matched standardized norms. The normal data is available from a pre-existing Gait Repository, a collection of gait parameters in children without a specific diagnosis studied at Oregon Health and Science University. The results will be converted to centile charts with the aid of a biostatistician. Centile charts will be used to track statistical changes over time in the following gait parameters including but not exclusive to:  velocity, cadence, step length, and base of support.", 
            "measure": "Measurable changes in gait", 
            "safety_issue": "No", 
            "time_frame": "36 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01920828"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Oregon Health and Science University", 
            "investigator_full_name": "Abigail Hata", 
            "investigator_title": "Abigail Hata, MS CGC", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Oregon Health and Science University", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "University of Utah", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "BioMarin Pharmaceutical", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "Oregon Health and Science University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2013"
    }
}